Research News

---

Topic: Hormonal Therapies (view all topics)

Tags for topic Hormonal Therapies:

• After surgery (also called "adjuvant")
• Arimidex
• Aromasin
• Aromatase Inhibitors
• Before surgery (also called "neoadjuvant")
• Evista
• Fareston
• Faslodex
• Femara
• Not applicable (no surgery)
• Planning Hormonal Therapy
• Prophylactic (to lower risk if you've never been diagnosed with breast cancer)
• Selective Estrogen Receptor Modulators
• Tamoxifen

View articles by month and year

• Estradiol Therapy May Help Some Advanced-Stage Breast Cancers Start Responding to Hormonal Therapy Again

  Published on August 18, 2009 at 12:00 am

  • Tags: Arimidex, Aromasin, Femara, After surgery (also called "adjuvant"), and Aromatase Inhibitors

  A small study found that estradiol, a form of estrogen, was an effective treatment for about 30% of advanced-stage, hormone-receptor-positive breast cancers that had stopped responding to hormonal therapy.

• Aromasin Slightly Better than Tamoxifen at Reducing Recurrence Risk

  Published on December 15, 2008 at 12:00 am

  • Tags: Aromasin, Tamoxifen, After surgery (also called "adjuvant"), and Planning Hormonal Therapy

  Research shows that the aromatase inhibitor Aromasin reduces the risk of the cancer coming back somewhat better than tamoxifen in post-menopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer.

• Aromatase Inhibitors Slightly Better Than Tamoxifen for Postmenopausal Women

  Published on December 12, 2008 at 12:00 am

  • Tags: Arimidex, Aromasin, Femara, Tamoxifen, After surgery (also called "adjuvant"), Aromatase Inhibitors, and Planning Hormonal Therapy

  A review of a number of studies confirms that aromatase inhibitors reduce the risk of early-stage, hormone-receptor-positive breast cancer coming back better than tamoxifen in post-menopausal women.

• Estradiol May Make Breast Cancer Start Responding to Aromatase Inhibitors Again

  Published on December 12, 2008 at 12:00 am

  • Tags: Arimidex, Aromasin, Femara, and Aromatase Inhibitors

  A small study found that estradiol, a form of estrogen, can make advanced-stage, hormone-receptor-positive breast cancers that have stopped responding to hormonal therapy start responding again in some cases.

• Hormonal Therapy Side Effects Linked to Lower Risk of Recurrence

  Published on October 29, 2008 at 12:00 am

  • Tags: Arimidex, Aromasin, Femara, Tamoxifen, After surgery (also called "adjuvant"), and Aromatase Inhibitors

  New research suggests a link between hormonal therapy side effects (hot flashes, night sweats, joint pain) and a reduced risk of breast cancer coming back.

• High Estrogen Levels May Lead to Recurrence

  Published on March 6, 2008 at 12:00 am

  • Tags: Arimidex, Aromasin, Femara, Tamoxifen, After surgery (also called "adjuvant"), and Aromatase Inhibitors

  Women diagnosed with early-stage breast cancer that came back (recurred) had higher blood estrogen levels than women diagnosed with early-stage breast cancer that didn't come back.

• Different Hormonal Therapies Cause Different Side Effects

  Published on November 14, 2007 at 12:00 am

  • Tags: Aromasin, Tamoxifen, and After surgery (also called "adjuvant")

  Hormonal therapy medicines used to reduce the risk of recurrence have different side effects.

• Chemotherapy and Aromatase Inhibitors Can Cause Bone Loss

  Published on September 19, 2007 at 12:00 am

  • Tags: Arimidex, Aromasin, Femara, After surgery (also called "adjuvant"), and Aromatase Inhibitors

  A new study provides more evidence that bone loss is a significant risk for women who receive chemotherapy and/or an aromatase inhibitor to treat breast cancer.

• Women Stop Taking Hormonal Therapy Too Soon Because of Side Effects

  Published on September 6, 2007 at 12:00 am

  • Tags: Arimidex, Aromasin, Femara, Tamoxifen, After surgery (also called "adjuvant"), and Aromatase Inhibitors

  Side effects cause many women to stop taking hormonal therapy medicine earlier than prescribed a new study reports.

• Hormonal Therapy Medicines Have Improved Survival

  Published on April 23, 2007 at 12:00 am

  • Tags: Arimidex, Aromasin, Femara, Tamoxifen, After surgery (also called "adjuvant"), Aromatase Inhibitors, and Planning Hormonal Therapy

  Hormone-receptor-positive breast cancer survival rates have increased faster than survival rates for hormone-receptor-negative breast cancer.